Cathie Wood Says Software Is the Next Big AI Opportunity -- 2 Ark ETFs You'll Want to Buy if She's Right
Cathie Wood is the founder of Ark Investment Management, which operates several exchange-traded funds (ETFs) focused on innovative technologies. In 2023, she predicted software companies would be the ...
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is ...
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva’s lead product candidate, lanifibranor, is currently in a pivotal Phase III clinical trial, NATiV3, for the treatment of adult patients with MASH, a common and progressive chronic liver ...
There’s Still Time to Surf Broadcom’s AI Semiconductor Wave
Shares of semiconductor giant Broadcom (AVGO) have almost doubled over the past year. Invest with Confidence: Follow TipRanks' Top Wall Street ...
Joe Gibbs Racing and Saia LTL Freight Announce Multi-Year Partnership for Ty Gibbs and No. 54 Toyota Camry XSE
HUNTERSVILLE, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Saia Inc. (NASDAQ: SAIA) is excited to announce that Saia LTL Freight has partnered with Joe Gibbs Racing for a multi-year sponsorship of Ty Gibbs ...
Macerich Announces Appointment of Devin Murphy to Board of Directors
SANTA MONICA, Calif., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced ...
WISeKey Announces HUMAN-AI-T, Universal AI for Humanity Platform, at Davos
T, Universal AI for Humanity Platform, at Davos View video hereDavos, January 24, 2025 – WISeKey International Holding ...
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February ...
CareCloud Shareholders Tentatively Approve Proposal to Increase Authorized Common Shares with Record Voter Turnout
Approximately 10.4 million votes by proxy have been returned (the “votes”) in favor of increasing the authorized number of shares of common stock from 35 million to 85 million shares, marking one of ...
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, ...
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
Credit Acceptance Announces Timing of Fourth Quarter 2024 Earnings Release and Webcast
Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we expect to issue a news release with our fourth quarter ...